Name: Domellöf Magnus
Date: 26.11.2025
Grants or contracts
Entity with whom you have this relationship: Arla Foods Ingredients
Details / Comments: Research study support made to my institution
Percentage: 0%
Estimate % of your annual research income from this activity: 10%
Entity with whom you have this relationship: Elgan Pharma
Details / Comments: Research study support made to my institution
Percentage: 0%
Estimate % of your annual research income from this activity: 0%
Consulting fees
Entity with whom you have this relationship: Elgan Pharma
Details / Comments: Consultant / on Scientific Steering Committee. Payment made to me.
Percentage: <5%
Estimate % of your annual research income from this activity: 1%
Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events
Entity with whom you have this relationship: Danone Nutricia
Details / Comments: Speaker fee. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: Baxter Medical AB
Details / Comments: Speaker fees. Payments made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: Fresenius Kabi Deutschland GmbH
Details / Comments: Symposium speaker ESPGHAN 2024. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: Institut Produits Synthése (IPSEN) AB
Details / Comments: Speaker fee. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Payment for expert testimony
Entity with whom you have this relationship: Intertek Health Sciences Inc.
Details / Comments: Subject matter expert statement on ‘DHA and Preterm Infants – An Assessment of Safety’. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: Fresenius Kabi Deutschland GmbH
Details / Comments: Author of expert statement on trace elements in parenteral nutrition. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Support for attending meetings and/or travel
Entity with whom you have this relationship: Baxter Medical AB
Details / Comments: Travel support
Percentage: 0%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: Fresenius Kabi Deutschland GmbH
Details / Comments: Travel support
Percentage: 0%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: Nestle Sverige AB
Details / Comments: Travel support
Percentage: 0%
Estimate % of your annual research income from this activity: 0%
Safety Monitoring Board or Advisory Board
Entity with whom you have this relationship: Baxter Healthcare Corporation
Details / Comments: Participation on Neonatal Medical Advisory Board at jENS in Rome 2023. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Entity with whom you have this relationship: BioGaia AB
Details / Comments: Advisory Board meeting to discuss a new product from BioGaia AB. Payment made to me.
Percentage: <1%
Estimate % of your annual research income from this activity: 0%
Stock or stock options
Entity with whom you have this relationship: Nutrium AB
Details / Comments: Founder and CEO. Any payments made to me.
Percentage: 0%
Estimate % of your annual research income from this activity: 0%